Uncategorized
Ocular Therapeutix™ to Present at the 30th Annual Piper Jaffray Healthcare Conference
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018 at 3:00 PM ET at the Lotte New York Palace Hotel in New York, NY. In ad